PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

E. G. Schuetz; M. V. Relling; S. Kishi; W. Yang; S. Das; P. Chen; E. H. Cook; G. L. Rosner; C. H. Pui; J. G. Blanco; M. J. Edick; M. L. Hancock; N. J. Winick; T. Dervieux; M. D. Amylon; R. O. Bash; F. G. Behm; B. M. Camitta; S. C. Raimondi; B. C. Goh; S. C. Lee; L. Z. Wang; L. Fan; J. Y. Guo; J. Lamba; R. Lim; H. L. Lim; A. B. Ong; H. S. Lee; P. Kuehl; J. Zhang; Y. Lin; M. Assem; J. Schuetz; P. B. Watkins; A. Daly; S. A. Wrighton; S. D. Hall; P. Maurel; C. Brimer; K. Yasuda; R. Venkataramanan; S. Strom; K. Thummel; M. S. Boguski

doi:10.1124/pr.56.2.1

PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

E. G. Schuetz, M. V. Relling, S. Kishi, W. Yang, S. Das, P. Chen, E. H. Cook, G. L. Rosner, C. H. Pui, J. G. Blanco, M. J. Edick, M. L. Hancock, N. J. Winick, T. Dervieux, M. D. Amylon, R. O. Bash, F. G. Behm, B. M. Camitta, S. C. Raimondi, B. C. GohS. C. Lee, L. Z. Wang, L. Fan, J. Y. Guo, J. Lamba, R. Lim, H. L. Lim, A. B. Ong, H. S. Lee, P. Kuehl, J. Zhang, Y. Lin, M. Assem, J. Schuetz, P. B. Watkins, A. Daly, S. A. Wrighton, S. D. Hall, P. Maurel, C. Brimer, K. Yasuda, R. Venkataramanan, S. Strom, K. Thummel, M. S. Boguski

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Original language	English (US)
Pages (from-to)	159
Number of pages	1
Journal	Pharmacological reviews
Volume	56
Issue number	2
DOIs	https://doi.org/10.1124/pr.56.2.1
State	Published - Jun 2004

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

Access to Document

10.1124/pr.56.2.1

Cite this

Schuetz, E. G., Relling, M. V., Kishi, S., Yang, W., Das, S., Chen, P., Cook, E. H., Rosner, G. L., Pui, C. H., Blanco, J. G., Edick, M. J., Hancock, M. L., Winick, N. J., Dervieux, T., Amylon, M. D., Bash, R. O., Behm, F. G., Camitta, B. M., Raimondi, S. C., ... Boguski, M. S. (2004). PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5. Pharmacological reviews, 56(2), 159. https://doi.org/10.1124/pr.56.2.1

Schuetz, EG, Relling, MV, Kishi, S, Yang, W, Das, S, Chen, P, Cook, EH, Rosner, GL, Pui, CH, Blanco, JG, Edick, MJ, Hancock, ML, Winick, NJ, Dervieux, T, Amylon, MD, Bash, RO, Behm, FG, Camitta, BM, Raimondi, SC, Goh, BC, Lee, SC, Wang, LZ, Fan, L, Guo, JY, Lamba, J, Lim, R, Lim, HL, Ong, AB, Lee, HS, Kuehl, P, Zhang, J, Lin, Y, Assem, M, Schuetz, J, Watkins, PB, Daly, A, Wrighton, SA, Hall, SD, Maurel, P, Brimer, C, Yasuda, K, Venkataramanan, R, Strom, S, Thummel, K & Boguski, MS 2004, 'PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.', Pharmacological reviews, vol. 56, no. 2, pp. 159. https://doi.org/10.1124/pr.56.2.1

@article{090ae052f8cc4299b56447783b1e3167,

title = "PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.",

author = "Schuetz, {E. G.} and Relling, {M. V.} and S. Kishi and W. Yang and S. Das and P. Chen and Cook, {E. H.} and Rosner, {G. L.} and Pui, {C. H.} and Blanco, {J. G.} and Edick, {M. J.} and Hancock, {M. L.} and Winick, {N. J.} and T. Dervieux and Amylon, {M. D.} and Bash, {R. O.} and Behm, {F. G.} and Camitta, {B. M.} and Raimondi, {S. C.} and Goh, {B. C.} and Lee, {S. C.} and Wang, {L. Z.} and L. Fan and Guo, {J. Y.} and J. Lamba and R. Lim and Lim, {H. L.} and Ong, {A. B.} and Lee, {H. S.} and P. Kuehl and J. Zhang and Y. Lin and M. Assem and J. Schuetz and Watkins, {P. B.} and A. Daly and Wrighton, {S. A.} and Hall, {S. D.} and P. Maurel and C. Brimer and K. Yasuda and R. Venkataramanan and S. Strom and K. Thummel and Boguski, {M. S.}",

note = "Funding Information: We thank J. Schietecatte for performing PRL assays, Dr. I. Van Riet for providing blasts from patients with AML and Dr. R. Hooghe for critically reading the manuscript. This research has been funded by the Flemish Government (GOA{\textquoteright}s), the Fund for Scientific Research-Flanders, Belgium (F.W.O.) and institutional grants from the V.U.B. Ron Kooijman is a research associate of the Fund for Scientific Research-Flanders, Belgium (F.W.O.).",

year = "2004",

month = jun,

doi = "10.1124/pr.56.2.1",

language = "English (US)",

volume = "56",

pages = "159",

journal = "Pharmacological reviews",

issn = "0031-6997",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "2",

}

TY - JOUR

T1 - PharmGKB update

T2 - II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

AU - Schuetz, E. G.

AU - Relling, M. V.

AU - Kishi, S.

AU - Yang, W.

AU - Das, S.

AU - Chen, P.

AU - Cook, E. H.

AU - Rosner, G. L.

AU - Pui, C. H.

AU - Blanco, J. G.

AU - Edick, M. J.

AU - Hancock, M. L.

AU - Winick, N. J.

AU - Dervieux, T.

AU - Amylon, M. D.

AU - Bash, R. O.

AU - Behm, F. G.

AU - Camitta, B. M.

AU - Raimondi, S. C.

AU - Goh, B. C.

AU - Lee, S. C.

AU - Wang, L. Z.

AU - Fan, L.

AU - Guo, J. Y.

AU - Lamba, J.

AU - Lim, R.

AU - Lim, H. L.

AU - Ong, A. B.

AU - Lee, H. S.

AU - Kuehl, P.

AU - Zhang, J.

AU - Lin, Y.

AU - Assem, M.

AU - Schuetz, J.

AU - Watkins, P. B.

AU - Daly, A.

AU - Wrighton, S. A.

AU - Hall, S. D.

AU - Maurel, P.

AU - Brimer, C.

AU - Yasuda, K.

AU - Venkataramanan, R.

AU - Strom, S.

AU - Thummel, K.

AU - Boguski, M. S.

N1 - Funding Information: We thank J. Schietecatte for performing PRL assays, Dr. I. Van Riet for providing blasts from patients with AML and Dr. R. Hooghe for critically reading the manuscript. This research has been funded by the Flemish Government (GOA’s), the Fund for Scientific Research-Flanders, Belgium (F.W.O.) and institutional grants from the V.U.B. Ron Kooijman is a research associate of the Fund for Scientific Research-Flanders, Belgium (F.W.O.).

PY - 2004/6

Y1 - 2004/6

UR - http://www.scopus.com/inward/record.url?scp=10044288943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044288943&partnerID=8YFLogxK

U2 - 10.1124/pr.56.2.1

DO - 10.1124/pr.56.2.1

M3 - Article

C2 - 15169924

AN - SCOPUS:10044288943

SN - 0031-6997

VL - 56

SP - 159

JO - Pharmacological reviews

JF - Pharmacological reviews

IS - 2

ER -

PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this